Sales rise 30.53% to Rs 13.68 crore
Posts in category Business Standard
Uniinfo Telecom Services reports consolidated net profit of Rs 0.16 crore in the December 2023 quarter (16-02-2024)
Sales rise 83.49% to Rs 13.67 crore
Vibhor Steel Tubes IPO ends with blockbuster subscription (16-02-2024)
The offer received bids for 107.36 crore shares as against 0.35 crore shares on offer.
Indices climb for 4th day on positive global cues; M&M spurts 4% (16-02-2024)
Domestic equity benchmarks ended with decent gains on Friday, rising for the fourth day in a row. The positive global cues propelled Indian equity indices into the green, leading to a sustained upward trend throughout the session, with Nifty consistently remaining above the 22,000 mark. Auto, IT and pharma shares were in demand, while oil & gas, PSU banks declined.
Entero Healthcare Solutions shares slip 9% on stock market debut (16-02-2024)
Entero’s weak listing follows a lukewarm response to its Rs 1,600-crore IPO. The maiden share sale had garnered just 1.5 times subscription
NSE SME IPO Esconet Technologies subscribed 6.11 times (16-02-2024)
The offer received bids for 2.05 crore shares as against 33.60 lakh shares on offer.
INR Edges Higher On Positive Cues From Local Equities (16-02-2024)
The Indian rupee rose 4 paise to settle at 83.01 (provisional) against the US dollar on Friday, amid positive sentiment in the domestic equity markets and softening crude oil prices. The benchmark S&P BSE Sensex ended the session up 376.26 points, or 0.52 percent, at 72,426.64, mirroring gains in the global markets. The broader NSE Nifty index settled 129.95 points, or 0.59 percent, higher at 22,040.70, with auto stocks leading the surge. Meanwhile, a strong American currency and outflow of foreign funds capped a sharp gain in the domestic currency. The dollar index continues to hover above 104 mark although it rebounded from overnight sharp drop. At the interbank foreign exchange market, the local unit opened at 83.03 and touched the intraday high of 83.00 against the greenback.
Zydus Life hits record high on USFDA nod for chest pain prevention drug (16-02-2024)
Zydus Lifesciences added 1.38% to Rs 891.60 after it received final approval from US Food & Drug Administration (USFDA) for manufacturing and marketing of Isosorbide Mononitrate extended-release tablets.
Nifty February futures trade at premium (16-02-2024)
HDFC Bank, SBI and M&M were the top traded contracts.
Euro Steadying Below $1.08 Mark; ECB’s Isabel Cautions Not To Adjust Policy Stance Prematurely (16-02-2024)
The euro is seen steadying on Friday following European Central Bank (ECB) executive board member Isabel Schnabel comments that we must be cautious not to adjust policy stance prematurely. Monetary policy needs to remain restrictive until we can be confident that inflation will sustainably return to our medium-term target, she added. Euro is staying slightly short of reclaiming $1.08 mark but coming off three-month lows touched during the week. EURUSD is currently trading at $1.0779, down marginally on the day. The Dollar coming off recent peaks following weaker than expected US retail sales data capped downside in the single common currency. The dollar index that measures the greenback against a basket of currencies recovered some lost ground and was trading at 104.27 today after having fallen over half a percent yesterday. The 10-year benchmark treasury yields also dipped to around 4.22%.